Fri, September 29, 2023

Danielle Antalffy Initiated (TMCI) at Strong Buy and Held Target at $24 on, Sep 29th, 2023

Danielle Antalffy of UBS, Initiated "Treace Medical Concepts, Inc." (TMCI) at Strong Buy and Held Target at $24 on, Sep 29th, 2023.

Danielle has made no other calls on TMCI in the last 4 months.



There are 3 other peers that have a rating on TMCI. Out of the 3 peers that are also analyzing TMCI, 1 agrees with Danielle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Reiterated at Hold and Held Target at $25 on, Tuesday, September 12th, 2023


These are the ratings of the 2 analyists that currently disagree with Danielle


  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, August 28th, 2023
  • Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, August 9th, 2023